Monthly Archives: April 2020

Myocardial Injury Common and Risky in COVID-19

This entry was posted in Cardiovascular Diseases Uncategorized and tagged COVID-19 CVD Myocardial Injury on by

A retrospective cohort study in the US suggested that myocardial injury was prevalent among patients hospitalized with COVID-19, and was associated with higher risk of mortality. The study included 2736 patients (median age 66.4 years, 59.6% men) with COVID-19 admitted between February 27th and April 12th, 2020 with troponin-I (normal […]

Hydroxychloroquine plus Azithromycin May be Risky

This entry was posted in Cardiovascular Diseases Uncategorized and tagged Azithromycin Hydroxychloroquine on by

International cohort studies suggest that adding azithromycin to hydroxychloroquine (HCQ) treatment may increase heart failure and cardiovascular mortality, potentially due to synergistic effects on QT length of ECG. Severe adverse events associated with HCQ-azithromycin were compared to HCQ-amoxicillin in rheumatoid arthritis patients aged 18+ and followed up over 30 days. […]